comparemela.com
Home
Live Updates
Iopofosine I 131 Generates Early Efficacy Signals in Waldenström Macroglobulinemia : comparemela.com
Iopofosine I 131 Generates Early Efficacy Signals in Waldenström Macroglobulinemia
Iopofosine I 131 monotherapy elicited durable responses and was associated with a tolerable safety profile in patients with heavily pretreated, multi-class refractory Waldenström macroglobulinemia.
Related Keywords
James Caruso ,
Cellectar Biosciences ,
,
Iopofosinei 131 Monotherapy ,
Patients With Heavily Pretreated ,
Ulti Class Refractory Waldenström Macroglobulinemia ,
Clover Wam Trial ,
Nct02952508 ,
Sikander Ailawadhi ,
D ,
Mayo Clinic ,
Newton Guerin ,
comparemela.com © 2020. All Rights Reserved.